MarginsXMarginsX
Home › Markets › Health Care › MTVA

MetaVia Inc. (MTVA)

MTVA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.21
-7.31% on the day
Market cap
$8.1M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerMTVA on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2016
SEC CIK0001638287
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Warning signs

Cash runway
9.6 months
$12.6M cash at June 30, 2026
Share count, 1 year
+206.3%
2025-11-05 to 2026-11-09 · +1428.8% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about our ability to continue as a going concern within one year from the issuance of these condensed consolidated financial statements."
10-Q 2026-11-13
Cash and burn$12.6M cash; operating cash flow -$4.0M a quarter.Report 2026-06-30
Shares outstanding6,742,889 (2026-11-09); 24,214,788 a year earlier; 38,812,518 three years earlier. 1y figure adjusted for splits (1-for-11 overall); 3y figure adjusted for splits (1-for-88 overall).Cover page 2026-11-09
Reverse splits, 3 years2; latest 1-for-11 on 2025-12-05Source 2025-12-05
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2026-07-02
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2025-11-26
AuditorBDO USA, P.C., Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-26
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$5.3M-$3.8M$12.6MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q1 2026
2026-03-31
Not filed-$3.8M-$4.3M$13.7MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q4 2025
2025-12-31
Not filed-$1.9M-$4.9M$10.3MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2025
2025-09-30
Not filed-$3.4M-$3.0M$14.3MNo debt tagsNeeds four quarters10-Q 2025-11-06
Q2 2025
2025-06-30
Not filed-$4.0M-$3.1M$17.6MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q1 2025
2025-03-31
Not filed-$3.7M-$4.8M$11.2MNo debt tagsNeeds four quarters10-Q 2026-08-06
Q4 2024
2024-12-31
Not filed-$5.2M-$5.5M$16.0MNo debt tagsNeeds four quarters10-K 2026-03-26
Q3 2024
2024-09-30
Not filed-$5.7M-$5.5M$21.7MNo debt tagsNeeds four quarters10-Q 2025-11-06

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-02
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-04-27

Source: SEC EDGAR submissions feed, 637 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-9.1%
1 month-9.1%
3 months-11.0%
Year to date-84.6%
1 year-82.1%
From 52-week high-88.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CALCCalciMedica Inc.$1.19-1.65%$8.2M
RKTORocket One Inc.$0.3210+0.03%$8.0M
ENSCEnsysce Biosciences Inc.$0.4095-2.13%$8.0M
VTGNVistagen Therapeutics Inc.$0.1843+2.11%$8.5M
MBRXMoleculin Biotech Inc.$7.14-9.28%$7.6M
UPCUniverse Pharmaceuticals Inc.$1.48-1.99%$7.4M
PHIOPhio Pharmaceuticals Corp.$0.7522-2.44%$9.0M
BFRGBullfrog AI Holdings Inc.$0.4878-9.92%$9.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier